Likely pathogenic variant in the BICD2 gene in fetus presenting with non‐immune hydrops
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6386 ↗Kurz gefasst
Fallbericht in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Natalie Chandler und 3 weiteren Autor:innen. Beteiligte Einrichtung: North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Microtubule-Associated Proteins, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIHR Biomedical Research Centre, Great Ormond Street Hospital.
Abstract (Originalsprache)
Trio exome sequencing was performed on a fetus presenting with severe hydrops fetalis at 21 + 0 weeks gestation. A novel de novo BICD2 missense variant was identified in the fetus. Pathogenic variants in the BICD2 gene are associated with lower extremity‐predominant spinal muscular atrophy. The variant was initially classified as a variant of uncertain clinical significance (VUS) as at the time of analysis and initial report, pathogenic variants in the BICD2 gene specifically had not been associated with fetal hydrops and no other abnormalities had been detected. It was agreed in multidisciplinary team discussions to include the variant in the report as a VUS recommending phenotypic follow‐up. The pregnancy was terminated and post‐mortem findings were in keeping with a BICD2 ‐pathogenic variant. In addition, a paper was published reporting another case with a pathogenic BICD2 variant presenting with fetal hydrops. The variant classification was then upgraded to class 4 likely pathogenic and reported as consistent with the diagnosis. This case demonstrates the importance of reporting these new gene/phenotypes in enabling others in the classification of variants, staying up‐to‐date with literature and following up phenotype for class 3 variants of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
- Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.
ORCID-Profile: Natalie Chandler, Rhiannon Mellis
Förderung
- NIHR Biomedical Research Centre, Great Ormond Street Hospital
Zitieren
APA
Chandler, N., Brace, P., Roberts, R., & Mellis, R. (2023). Likely pathogenic variant in the BICD2 gene in fetus presenting with non‐immune hydrops. Prenatal Diagnosis. https://doi.org/10.1002/pd.6386
Vancouver
Chandler N, Brace P, Roberts R, Mellis R. Likely pathogenic variant in the BICD2 gene in fetus presenting with non‐immune hydrops. Prenatal Diagnosis. 2023. doi:10.1002/pd.6386
BibTeX
@article{Chandler2023,
author = {Chandler, Natalie and Brace, Poppy and Roberts, Rowenna and Mellis, Rhiannon},
title = {Likely pathogenic variant in the BICD2 gene in fetus presenting with non‐immune hydrops},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6386}
}
EUVIMED